The role of sex and gender in the diagnosis and treatment of lungcancer: the 6th ICAPEM Annual Symposium

The incidence and mortality of lung cancer in women are rising, with both increasing by 124% between 2003 and 2019. The main risk factor for lung cancer is tobacco use, but indoor radon gas exposure is one of the leading causes in nonsmokers. The most recent evidence demonstrates that multiple factors can make women more susceptible to harm from these risk factors or carcinogens. For this consensus statement, the Association for Lung Cancer Research in Women (ICAPEM) invited a group of lung cancer experts to perform a detailed gender-based analysis of lung cancer. Clinically, female patients have diferent lung cancer profles, and most actionable driver alterations are more prevalent in women, particularly in never-smokers.

Additionally, the impact of certain therapies seems to be diferent. In the future, it will be necessary to carry out specifc studies to improve the understanding of the role of certain biomarkers and gender in the prognosis and evolution of lung cancer.

COMPARTE
Twitter
Facebook
LinkedIn
WhatsApp
Email
Twitter
Facebook
LinkedIn
WhatsApp
Email

ÚLTIMAS NOTICIAS

Programa ACTÍVATE 2024

Ser físicamente activo, tras el diagnóstico de cáncer y durante el tratamiento, puede facilitar el proceso de recuperación y mejorar

Leer Más >
Search
Trabajamos para prevenir, tratar, investigar y concienciar sobre el cáncer de pulmón en mujeres
Tactics MD logotipo

TACTICS
Passatge Batlló 15
08036 Barcelona (España)

secretaria@icapem.es

00.34.93.452.79.18

COLABORA

La información contenida en ese sitio web está dirigida exclusivamente a profesional sanitario facultado para prescribir o dispensar medicamentos en España ( requiere una formación especializada para su correcta interpretación).

Scroll to Top